GlassScriptPhysician profile
Brian Jacob Johnson
NPI 1689134710
$1,225.94
in general payments reported to CMS, 2019-2025
11 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $131 · 2024: $440 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,225.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $549.16 | 2024-2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Acclarent, INC | $130.93 | 2023 | Trudi Nav Cable |
| Advanced Bionics, LLC | $119.69 | 2024-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Inspire Medical Systems, INC. | $107.81 | 2024-2025 | Inspire |
| Med-El Corporation | $85.77 | 2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Genzyme Corporation | $72.26 | 2025 | |
| Optinose US, INC. | $48.18 | 2024 | |
| Stryker Corporation | $35.50 | 2024 | Audion Et Dilation System |
| Phathom Pharmaceuticals, INC. | $29.63 | 2024-2025 | Voquezna |
| Ars Pharmaceuticals Operations, INC. | $25.22 | 2025 | Neffy |
| Astrazeneca Pharmaceuticals LP | $21.79 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.